Navigating Challenges in Leukoplakia Management
Alessandro Villa, D.D.S., Ph.D., M.P.H. is founding chief of oral medicine, oral oncology and dentistry at Miami Cancer Institute where he also serves as the Program Director of the Oral Oncology Fellowship. In addition, he is a Professor at the Herbert Wertheim College of Medicine, Florida International University. Dr. Villa specializes in treating oral mucosal and salivary gland diseases, oral precancers and oral complications from cancer treatment. Prior to joining Miami Cancer Institute in 2022, Dr. Villa was an attending physician at the University of California San Francisco (UCSF). He also directed the oral medicine residency programs at UCSF and Harvard.
Dr. Villa’s research focuses on oral dysplasia, oral complications from cancer therapy and prevention of HPV-associated oropharyngeal cancers. He is involved in several investigator initiated and sponsored clinical trials and has published more than 130 peer-reviewed manuscripts.
Disclosure: Dr. Villa receives royalties from UpToDate, research support from Mureva and PCCA, and is a consultant for Merck, Afyx Therapeutics, K Pharma and Lipella Pharmaceuticals.
Attendees will learn to identify the various forms of leukoplakia, and associated risk factors. Attendees will also gain valuable insights into the multidisciplinary management of leukoplakia,and familarize with cutting-edge treatment alternatives for oral leukoplakia. By discussing the potential benefits and limitations of these emerging treatment options, participants will be empowered to make informed decisions about integrating novel therapies into their clinical practice.
- Recognize the clinical presentation of oral leukoplakia and other oral potentially malignant disorders
- Apply current management strategies for oral leukoplakia.
- Explore and discuss innovative treatment alternatives for oral leukoplakia.